Quick Takeaways: Why It Matters? AKC Canine Health Foundation is elevating canine geroscience from scattered projects to a focused Aging program, anchored by new global guidelines that standardize how vets diagnose and monitor Canine Cognitive Dysfunction Sy...
Quick Takeaways: Why It Matters? BiomEdit’s new patents effectively lock up its engineered Lactobacillus reuteri pvAb platform, giving it composition‑of‑matter and methods‑of‑use protection around BE‑101 and future in situ biologic payloads delivered vi...
Quick Takeaways: Why It Matters? Gallant’s positive UMSC pilot data and FDA CVM’s expanded conditional approval eligibility together position this program as a potential first‑in‑class, disease‑modifying biologic in an almost empty feline OA toolbox. By showing up to...
Quick Takeaways: Why It Matters? BioTesserae’s BTC-001, a PD‑1–targeting single‑domain antibody for canine cancer, showed good tolerability in healthy dogs in a single‑ascending‑dose study, with doses up to three times the anticipated therapeutic level. Ins...
Quick Takeaways: Why It Matters? Lenzelta gives Boehringer Ingelheim a next‑generation mastitis vaccine that fits neatly into dry‑off protocols: two intramuscular doses in late gestation deliver early‑onset immunity and up to six months...
Quick Takeaways: Why It Matters? Bond Vet is layering a simple membership on top of its clinics to nudge clients into more frequent, preventative visits while locking in long‑term relationships. The limited-time Founding Member offer (100 dollars off enrolment from April ...
Quick Takeaways: Why It Matters? Elanco is extending its Advantage franchise into the collar segment with an over‑the‑counter, one‑size, water‑resistant dog collar that kills fleas and ticks and repels mosquitoes for four months, meaning most pets need only three collars per ye...
Quick Takeaways: Why It Matters? Chewy is using the Modern Animal acquisition to bolt a fast-growing, tech-enabled clinic network onto its retail, pharmacy, and insurance stack, expanding Chewy Vet Care from 18 to 47 locations and adding over 125 million dollars in hi...
Quick Takeaways: Why It Matters? Parnell is bolstering its US footprint by buying Noble Pharma, adding an FDA and DEA‑accredited plant in Wisconsin with broad dosage-form capabilities to secure supply and support portfolio growth. The acquisition turns Noble’s CDMO-style ...
Quick Takeaways: Why It Matters? Petwealth is positioning itself as an at‑home diagnostics and data layer for pet health, bundling fecal, oral, and respiratory PCR into a single kit and pairing 24–48‑hour lab results with AI‑generated insights and 24/7 tele-vet suppor...
